Eleison Pharmaceuticals Overview
- Year Founded
-
2009

- Status
-
Private
- Employees
-
2

- Latest Deal Type
-
Debt
- (Announced)
- Financing Rounds
-
6
Eleison Pharmaceuticals General Information
Description
Developer of a specialty pharmaceuticals and life-saving drugs intended for cancer treatment. The company acquires, develops and commercializes clinical-stage drug therapies for lung, pancreatic, brain and other types of cancers, thus providing patients with a new hope to fight these rare and life-threatening diseases.
Contact Information
Website
www.eleison-pharma.comCorporate Office
- 100 Overlook Center
- 2nd Floor
- Princeton, NJ 08540
- United States
Corporate Office
- 100 Overlook Center
- 2nd Floor
- Princeton, NJ 08540
- United States
Eleison Pharmaceuticals Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Eleison Pharmaceuticals Comparisons
Industry
Financing
Details
Eleison Pharmaceuticals Competitors (26)
One of Eleison Pharmaceuticals’s 26 competitors is Genentech, a Formerly VC-backed company based in South San Francisco, CA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Genentech | Formerly VC-backed | South San Francisco, CA | ||||
Northwest Biotherapeutics | Corporate Backed or Acquired | Bethesda, MD | ||||
Cardurion | Venture Capital-Backed | Burlington, MA | ||||
Ability Pharma | Private Equity-Backed | Barcelona, Spain | ||||
Pfizer Pakistan | Corporation | Karachi, Pakistan |
Eleison Pharmaceuticals Patents
Eleison Pharmaceuticals Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20220142941-A1 | Combination therapeutic regimens with 1,6-dibromo-1,6-dideoxy-dulcitol | Inactive | 24-Apr-2019 | ||
AU-2020262112-A1 | Combination therapeutic regimens with 1,6-dibromo-1,6-dideoxy-dulcitol | Pending | 24-Apr-2019 | ||
EP-3958848-A1 | Combination therapeutic regimens with 1,6-dibromo-1,6-dideoxy-dulcitol | Pending | 24-Apr-2019 | ||
JP-2022529990-A | Combination treatment regimen with 1,6-dibromo-1,6-dideoxy-zlucitol | Pending | 24-Apr-2019 | ||
CA-3137952-A1 | Combination therapeutic regimens with 1,6-dibromo-1,6-dideoxy-dulcitol | Pending | 24-Apr-2019 | A61K31/047 |
Eleison Pharmaceuticals Signals
Eleison Pharmaceuticals Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Eleison Pharmaceuticals FAQs
-
When was Eleison Pharmaceuticals founded?
Eleison Pharmaceuticals was founded in 2009.
-
Where is Eleison Pharmaceuticals headquartered?
Eleison Pharmaceuticals is headquartered in Princeton, NJ.
-
What is the size of Eleison Pharmaceuticals?
Eleison Pharmaceuticals has 2 total employees.
-
What industry is Eleison Pharmaceuticals in?
Eleison Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Eleison Pharmaceuticals a private or public company?
Eleison Pharmaceuticals is a Private company.
-
What is Eleison Pharmaceuticals’s current revenue?
The current revenue for Eleison Pharmaceuticals is
. -
How much funding has Eleison Pharmaceuticals raised over time?
Eleison Pharmaceuticals has raised $14M.
-
Who are Eleison Pharmaceuticals’s investors?
BDI Company and Pharm-Olam have invested in Eleison Pharmaceuticals.
-
Who are Eleison Pharmaceuticals’s competitors?
Genentech, Northwest Biotherapeutics, Cardurion, Ability Pharma, and Pfizer Pakistan are some of the 26 competitors of Eleison Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »